S. Shakir
发表
L. Hazell,
S. Shakir,
2006,
Drug safety.
S. Shakir,
J. Deeks,
A. Clarke,
2006,
Drug safety.
S. Shakir,
L. Wilton,
2002,
Epilepsia.
Dan M Roden,
Harold Snieder,
Vanessa Marshall,
2012,
Journal of the American College of Cardiology.
Marylyn D. Ritchie,
Thomas Meitinger,
Dana C. Crawford,
2012,
Circulation. Cardiovascular genetics.
S. Shakir,
A. Pariente,
A. Fourrier-Réglat,
2016,
Clinical pharmacology and therapeutics.
Use and Risk Management of Carvedilol for the Treatment of Heart Failure in the Community in England
S. Shakir,
L. Wilton,
B. Aurich-Barrera,
2009,
Drug safety.
S. Shakir,
Saad AW Shakir,
M. Perrio,
2007,
Drug safety.
L. Hazell,
S. Shakir,
A. Avery,
2013,
Drug Safety.
L. Hazell,
S. Shakir,
D. Layton,
2011,
Drug safety.
S. Shakir,
D. Layton,
D. Clark,
2001,
BMJ : British Medical Journal.
S. Shakir,
V. Osborne,
M. Davies,
2020,
Drug Safety.
S. Shakir,
V. Osborne,
S. Lane,
2020,
medRxiv.
S. Shakir,
V. Osborne,
M. Davies,
2020,
medRxiv.
S. Shakir,
D. Layton,
A. Coughtrie,
2017,
European Psychiatry.
S. Shakir,
D. Layton,
C. Fogg,
2014,
European journal of pain.
S. Shakir,
Y. Buggy,
D. Layton,
2010,
Epilepsia.
S. Shakir,
L. Wilton,
A. Boshier,
2006,
BJU international.
S. Shakir,
V. Osborne,
S. Lane,
2020,
medRxiv.
S. Shakir,
A. Clarke,
D. Layton,
2005,
Osteoporosis International.
S. Shakir,
L. Wilton,
P. Biswas,
2003,
Journal of psychopharmacology.
S. Shakir,
L. Wilton,
P. Biswas,
2003,
Osteoporosis International.
L. Friberg,
S. Shakir,
R. Herings,
2020,
Expert opinion on drug safety.
S. Shakir,
E. Heeley,
D. Layton,
2003,
Rheumatology.
S. Shakir,
D. Layton,
S. Harris,
2003,
Rheumatology.
J. Avorn,
S. Schneeweiss,
R. Glynn,
2003
.
S. Shakir,
A. Egberts,
D. Layton,
2008,
Drug safety.
S. Shakir,
C. Fogg,
R. Kasliwal,
2009,
Drug safety.
A post-marketing surveillance study of formoterol (Foradil): its use in general practice in England.
S. Shakir,
L. Wilton,
2002,
Drug safety.
S. Shakir,
L. Wilton,
2002
.
S. Shakir,
V. Cornelius,
L. Wilton,
2007,
Drug safety.
S. Shakir,
D. Layton,
G. Pearce,
2001,
European Journal of Clinical Pharmacology.
S. Shakir,
D. Layton,
L. Wilton,
2005,
British journal of clinical pharmacology.
S. Shakir,
P. Waller,
S. Evans,
2008,
Pharmacoepidemiology and drug safety.
S. Shakir,
L. Wilton,
S. Harris,
2005,
Osteoporosis International.
S. Shakir,
L. Wilton,
S. Harris,
2006,
Drug safety.
S. Shakir,
V. Cornelius,
Y. Buggy,
2013,
Drug Safety.
S. Shakir,
P. Waller,
M. Perrio,
2007,
Pharmacoepidemiology and drug safety.
S. Shakir,
E. Heeley,
D. Layton,
2003,
Rheumatology.
S. Shakir,
D. Layton,
S. Harris,
2004
.
S. Shakir,
V. Cornelius,
L. Wilton,
2009,
Drug safety.
S. Shakir,
L. Wilton,
M. Perrio,
2007,
Drug safety.
S. Shakir,
V. Cornelius,
Y. Buggy,
2011,
Drug safety.
S. Shakir,
V. Cornelius,
Lesley Smith,
2008
.
S. Shakir,
V. Cornelius,
M. Perrio,
2009,
Pharmacoepidemiology and drug safety.
S. Shakir,
V. Cornelius,
D. Layton,
2006,
Drug safety.
S. Shakir,
L. Wilton,
B. Twaites,
2007,
Drug safety.
S. Shakir,
D. Layton,
C. Fogg,
2018,
The International journal of pharmacy practice.
S. Shakir,
V. Osborne,
M. Davies,
2020,
BMJ Open.
S. Shakir,
N. Acharya,
P. M. Craig-McFeely,
2001,
European Journal of Clinical Pharmacology.
S. Shakir,
L. Wilton,
M. Perrio,
2007,
Pharmacoepidemiology and drug safety.
S. Shakir,
V. Osborne,
Jae Min,
2018,
Drug Safety.
S. Shakir,
L. Wilton,
G. Pearce,
2001,
Journal of psychopharmacology.
S. Shakir,
D. Layton,
V. Osborne,
2014,
Post reproductive health.
L. Hazell,
S. Shakir,
V. Cornelius,
2009,
BJU international.
Relative Risk of Vaginal Candidiasis After Use of Antibiotics Compared with Antidepressants in Women
S. Shakir,
E. Heeley,
L. Wilton,
2003,
Drug safety.
S. Shakir,
C. Bond,
P. Hannaford,
2002,
Pharmacoepidemiology and drug safety.
S. Shakir,
D. Layton,
Deborah Layton,
2003,
Pharmacoepidemiology and drug safety.
S. Shakir,
D. Layton,
G. Pearce,
2001,
Drug safety.
R. Altman,
Yufeng Shen,
Yusuke Nakamura,
2013,
PloS one.
S. Shakir,
L. Wilton,
M. Davies,
2013,
Drug Safety.
Emma Heeley,
S. Shakir,
E. Heeley,
2001,
The Lancet.
P. Munroe,
A. Camm,
S. Shakir,
2017
.
P. Munroe,
A. Camm,
S. Shakir,
2012
.
S. Shakir,
D. Layton,
Deborah Layton,
2002,
Pharmacoepidemiology and drug safety.
S. Shakir,
V. Osborne,
S. Lane,
2021,
Drug Safety.
S. Shakir,
D. Roy,
B. Amlani,
2021,
Journal of pediatric gastroenterology and nutrition.
S. Shakir,
L. Wilton,
Andrew Boshier,
2003,
European Journal of Clinical Pharmacology.
Emma Heeley,
S. Shakir,
E. Heeley,
2002,
Drug safety.
The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England
S. Shakir,
L. Wilton,
B. Twaites,
2006,
Journal of psychopharmacology.
S. Shakir,
V. Osborne,
M. Davies,
2020,
BMJ Evidence-Based Medicine.
S. Shakir,
D. Layton,
Deborah Layton,
2002,
Drug safety.
S. Shakir,
D. Layton,
V. Osborne,
2014,
Drug Safety.
E. Behr,
A. Camm,
S. Shakir,
2017,
BMJ Open.
S. Shakir,
R. McNaughton,
Gwenaël Huet,
2014,
BMJ Open.
L. Hazell,
S. Shakir,
L. Wilton,
2007,
BJU international.
L. Hazell,
S. Shakir,
P. Stolk,
2019,
Drug Safety.
L. Hazell,
S. Shakir,
D. Layton,
2010,
Drug safety.
S. A. W. Shakir,
S. Shakir,
2005
.
S. Shakir,
2004
.
S. Shakir,
E. Heeley,
D. Layton,
2001,
BMJ : British Medical Journal.
S. Shakir,
D. Layton,
A. Coughtrie,
2016,
Journal of clinical hypertension.
S. Shakir,
D. Layton,
L. Wilton,
2010,
Drug safety.
S. Shakir,
D. Layton,
2015,
Drug Safety.
S. Shakir,
V. Osborne,
S. Dhanda,
2020,
BMJ Evidence-Based Medicine.
S. Shakir,
T. MacDonald,
D. Layton,
2011,
British journal of clinical pharmacology.
S. Shakir,
D. Layton,
V. Osborne,
2018,
Drug Safety.
S. Shakir,
D. Layton,
L. Wilton,
2005,
Journal of psychopharmacology.
S. Shakir,
V. Osborne,
2019,
Pharmacoepidemiology.
S. Shakir,
Saad A. W. Shakir,
2012
.
S. Shakir,
L. Wilton,
R. Kasliwal,
2009,
Drug safety.
S. Shakir,
D. Layton,
L. Wilton,
2004,
European Journal of Clinical Pharmacology.
S. Shakir,
D. Layton,
L. Wilton,
2001,
Drug safety.
S. Priori,
E. Behr,
D. Roden,
2022,
Circulation. Genomic and precision medicine.
S. Shakir,
D. Layton,
G. Pearce,
2001,
European journal of clinical pharmacology.
S. Shakir,
D. Layton,
D. Clark,
2004,
Drug safety.
S. Shakir,
E. Heeley,
D. Layton,
2003,
Rheumatology.
S. Shakir,
M. Davies,
S. Lane,
2020,
Drug Safety.
S. Shakir,
D. Layton,
V. Marshall,
2006,
Drug safety.
S. Shakir,
S. Lane,
E. Lynn,
2018,
BMJ Open.
S. Shakir,
2007
.
S. Shakir,
V. Osborne,
M. Davies,
2020,
Therapeutic advances in psychopharmacology.
S. Shakir,
D. Layton,
P. Souverein,
2008,
Pharmacoepidemiology and drug safety.
S. Shakir,
L. Wilton,
M. Perrio,
2007,
Obesity.
S. Shakir,
D. Layton,
V. Osborne,
2011,
Drug safety.
S. Shakir,
D. Layton,
2014
.
S. Shakir,
T. MacDonald,
D. Layton,
2011
.
L. Hazell,
S. Shakir,
S. Boyer,
2017,
Journal of clinical pharmacology.
S. Shakir,
R. Mann,
L. Wilton,
2001
.
S. Shakir,
V. Osborne,
2021,
Frontiers in Pharmacology.
S. Shakir,
R. Pickering,
E. Heeley,
2001,
Journal of psychopharmacology.
S. Shakir,
L. Wilton,
M. Davies,
2008,
Drug safety.
S. Shakir,
V. Cornelius,
L. Wilton,
2010,
Journal of evaluation in clinical practice.
P. Munroe,
E. Behr,
D. Roden,
2012,
Journal of the American College of Cardiology.
S. Shakir,
Y. Buggy,
L. Wilton,
2013
.
S. Shakir,
D. Layton,
A. Coughtrie,
2016,
Drug Safety.
S. Shakir,
L. Wilton,
J. Cobert,
2006
.
S. Shakir,
D. Layton,
L. Wilton,
2012
.
S. Shakir,
V. Osborne,
M. Davies,
2020,
PloS one.
L. Hazell,
S. Shakir,
V. Cornelius,
2009,
BJU International.
L. Hazell,
S. Shakir,
D. Layton,
2011,
Drug safety.
S. Shakir,
D. Layton,
L. Wilton,
2002,
British journal of clinical pharmacology.
S. Shakir,
L. Wilton,
P. Biswas,
2001,
Drug safety.
P. Munroe,
S. Shakir,
H. Snieder,
2012,
Journal of the American College of Cardiology.
S. Shakir,
V. Marshall,
L. Wilton,
2006,
Acta Diabetologica.